Hypoglobulinemia in acromegaly
- PMID: 955558
- DOI: 10.1055/s-0028-1093639
Hypoglobulinemia in acromegaly
Abstract
We have observed an apparent hypoglobulinemia in 17 of 35 patients (48.6%) with acromegaly. This unexpected finding was persistent and reproducible up to six years for five acromegalic patients, and more than one year for nine other patients. Serum globulin was analyzed by three different methods, and the deficiency was most noticeable in the alpha globulin fraction (alpha1 greater than alpha2). When hypoglobulinemia occurred in control hospital in-patients (11%) it was associated with chronic or severe illnesses, and limited nutritional intake, but similar medical problems were absent in the acromegalic patients. There was no correlation of the hypoglobulinemia in the 35 acromegalic patients to their growth hormone (GH) concentration (r = 0.07), ages, sex, treatment status, or to the seriousness or duration of the acromegaly. The pathophysiology of the apparent hypoglobulinemia in acromegaly is unknown, but may be related to transport and/or disposal of excess growth hormone, or a defect in protein synthesis.
Similar articles
-
Hypoproteinemia in acromegaly.J Endocrinol Invest. 1979 Apr-Jun;2(2):217-9. doi: 10.1007/BF03349317. J Endocrinol Invest. 1979. PMID: 489930
-
Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.Exp Biol Med (Maywood). 2009 Aug;234(8):1002-9. doi: 10.3181/0901-RM-34. Epub 2009 Jun 2. Exp Biol Med (Maywood). 2009. PMID: 19491373
-
[Serum adiponectin levels in patients with acromegaly].Pol Merkur Lekarski. 2005 Oct;19(112):514-6. Pol Merkur Lekarski. 2005. PMID: 16379314 Polish.
-
GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.Clin Endocrinol (Oxf). 2008 Oct;69(4):613-20. doi: 10.1111/j.1365-2265.2008.03258.x. Epub 2008 Apr 10. Clin Endocrinol (Oxf). 2008. PMID: 18410555
-
Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.Clin Endocrinol (Oxf). 2005 Aug;63(2):168-75. doi: 10.1111/j.1365-2265.2005.02317.x. Clin Endocrinol (Oxf). 2005. PMID: 16060910
Cited by
-
Hypoproteinemia in acromegaly.J Endocrinol Invest. 1979 Apr-Jun;2(2):217-9. doi: 10.1007/BF03349317. J Endocrinol Invest. 1979. PMID: 489930
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources